Cargando…

Improvement of microvascular complications in STZ-diabetic rats treated with Pterocarpus erinaceus Poir. extract

Pterocarpus erinaceus Poir. from Fabaceae family is a medicinal plant traditionally used in decoction or infusion to treat diabetes mellitus. Although this plant is used in treating diabetes, studies on the effectiveness of its stem bark on the complications induced by chronic hyperglycemia have not...

Descripción completa

Detalles Bibliográficos
Autores principales: Atchou, Kokou, Lawson-Evi, Povi, Eklu-Gadegbeku, Kwashie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477066/
https://www.ncbi.nlm.nih.gov/pubmed/37674975
http://dx.doi.org/10.1016/j.bbrep.2023.101541
_version_ 1785101065091284992
author Atchou, Kokou
Lawson-Evi, Povi
Eklu-Gadegbeku, Kwashie
author_facet Atchou, Kokou
Lawson-Evi, Povi
Eklu-Gadegbeku, Kwashie
author_sort Atchou, Kokou
collection PubMed
description Pterocarpus erinaceus Poir. from Fabaceae family is a medicinal plant traditionally used in decoction or infusion to treat diabetes mellitus. Although this plant is used in treating diabetes, studies on the effectiveness of its stem bark on the complications induced by chronic hyperglycemia have not been thoroughly addressed. Thus, this study was conducted to prove the efficacy of hydroethanolic extract of stem bark of P. erinaceus on type 2 diabetes and its complications, such as renal fibrosis and retinopathy in rats. STZ diabetics. The dry extract of P. erinaceus stem bark was obtained following the hydroethanolic extraction (v/v). Diabetes was induced with streptozocin in SD rats pretreated with fructose-lard for 20 days. Then, the serum and urinary biochemical parameters were evaluated at the start and the end of the treatment. Rats with blood glucose ≥350 mg/dL and significant proteinuria were selected and treated with P. erinaceus stem bark extract and glibenclamide for 3 weeks. A complete blood count and a histopathological examination of the retina and kidneys were performed at the end of the 41st day of treatment. The results showed that P. erinaceus extract at a dose of 500 mg/kg bw and glibenclamide at a dose of 0.6 mg/kg bw caused a significant decrease (p < 0.0001) in basal blood glucose in STZ diabetic rats during treatment and improved oral glucose intolerance. At the end of the experiment, the treated rats showed a normalization in body weight, food and water consumption. Evaluating of biochemical parameters showed a significant (p < 0.001) decrease in total cholesterol, LDL-C, triglycerides, TG/HDL-C ratio, CPK and oxidative stress in treated rats. No retinal and kidney abnormalities were observed on histological sections in rats treated with plant extract and glibenclamide. In contrast, macular edema and renal fibrosis were observed in the diabetic control group. The findings showed that extract at a dose of 500 mg/kg bw improves oral glucose intolerance, and inhibits lipid deposition and retinal and renal fibrosis. Therefore, the plant extract could be exploited in the production of herbal medicines to manage diabetes and its complications.
format Online
Article
Text
id pubmed-10477066
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104770662023-09-06 Improvement of microvascular complications in STZ-diabetic rats treated with Pterocarpus erinaceus Poir. extract Atchou, Kokou Lawson-Evi, Povi Eklu-Gadegbeku, Kwashie Biochem Biophys Rep Research Article Pterocarpus erinaceus Poir. from Fabaceae family is a medicinal plant traditionally used in decoction or infusion to treat diabetes mellitus. Although this plant is used in treating diabetes, studies on the effectiveness of its stem bark on the complications induced by chronic hyperglycemia have not been thoroughly addressed. Thus, this study was conducted to prove the efficacy of hydroethanolic extract of stem bark of P. erinaceus on type 2 diabetes and its complications, such as renal fibrosis and retinopathy in rats. STZ diabetics. The dry extract of P. erinaceus stem bark was obtained following the hydroethanolic extraction (v/v). Diabetes was induced with streptozocin in SD rats pretreated with fructose-lard for 20 days. Then, the serum and urinary biochemical parameters were evaluated at the start and the end of the treatment. Rats with blood glucose ≥350 mg/dL and significant proteinuria were selected and treated with P. erinaceus stem bark extract and glibenclamide for 3 weeks. A complete blood count and a histopathological examination of the retina and kidneys were performed at the end of the 41st day of treatment. The results showed that P. erinaceus extract at a dose of 500 mg/kg bw and glibenclamide at a dose of 0.6 mg/kg bw caused a significant decrease (p < 0.0001) in basal blood glucose in STZ diabetic rats during treatment and improved oral glucose intolerance. At the end of the experiment, the treated rats showed a normalization in body weight, food and water consumption. Evaluating of biochemical parameters showed a significant (p < 0.001) decrease in total cholesterol, LDL-C, triglycerides, TG/HDL-C ratio, CPK and oxidative stress in treated rats. No retinal and kidney abnormalities were observed on histological sections in rats treated with plant extract and glibenclamide. In contrast, macular edema and renal fibrosis were observed in the diabetic control group. The findings showed that extract at a dose of 500 mg/kg bw improves oral glucose intolerance, and inhibits lipid deposition and retinal and renal fibrosis. Therefore, the plant extract could be exploited in the production of herbal medicines to manage diabetes and its complications. Elsevier 2023-09-02 /pmc/articles/PMC10477066/ /pubmed/37674975 http://dx.doi.org/10.1016/j.bbrep.2023.101541 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Atchou, Kokou
Lawson-Evi, Povi
Eklu-Gadegbeku, Kwashie
Improvement of microvascular complications in STZ-diabetic rats treated with Pterocarpus erinaceus Poir. extract
title Improvement of microvascular complications in STZ-diabetic rats treated with Pterocarpus erinaceus Poir. extract
title_full Improvement of microvascular complications in STZ-diabetic rats treated with Pterocarpus erinaceus Poir. extract
title_fullStr Improvement of microvascular complications in STZ-diabetic rats treated with Pterocarpus erinaceus Poir. extract
title_full_unstemmed Improvement of microvascular complications in STZ-diabetic rats treated with Pterocarpus erinaceus Poir. extract
title_short Improvement of microvascular complications in STZ-diabetic rats treated with Pterocarpus erinaceus Poir. extract
title_sort improvement of microvascular complications in stz-diabetic rats treated with pterocarpus erinaceus poir. extract
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477066/
https://www.ncbi.nlm.nih.gov/pubmed/37674975
http://dx.doi.org/10.1016/j.bbrep.2023.101541
work_keys_str_mv AT atchoukokou improvementofmicrovascularcomplicationsinstzdiabeticratstreatedwithpterocarpuserinaceuspoirextract
AT lawsonevipovi improvementofmicrovascularcomplicationsinstzdiabeticratstreatedwithpterocarpuserinaceuspoirextract
AT eklugadegbekukwashie improvementofmicrovascularcomplicationsinstzdiabeticratstreatedwithpterocarpuserinaceuspoirextract